ACTIVITY XANTHINE OXIDOREDUCTASE AND OXIDATIVE STRESS IN PLASMA HYPERTENSIVE AND HEART FAILURE PATIENTS ASSOCIATED WITH AGE-RELATED CATARACT

B. Kisić ,
B. Kisić

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

D. Mirić ,
D. Mirić

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

A. Stolić ,
A. Stolić

Institute for Preventive Medicine, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

I. Dragojević ,
I. Dragojević

Institute of Biochemistry, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

L. Žorić ,
L. Žorić

Clinic for Eye Diseases, Medical Faculty Priština , Kosovska Mitrovica , Kosovo*

M. Stanić
M. Stanić

Centre of Medical Biochemistry, Health Centre Kosovska Mitrovica , Kosovska Mitrovica , Kosovo*

Published: 01.01.2010.

Volume 38, Issue 1 (2010)

pp. 7-11;

https://doi.org/10.70949/pramed201001318K

Abstract

Oxidative stress and associated oxidative damage are mediators of vascular injury and inflammation in many cardiovascular diseases, including hypertension, atherosclerosis, ischemic heart disease, diabetes. Xanthine oxidoreductase is one of the enzymes producing free radicals in the cardiovascular system, and it can contribute to the increment of the oxidative stress and, consequently, blood pressure. The xanthine oxidase is a molybdoenzyme capable of catalyzing the oxidation of hypoxanthine and xanthine in the process of purine metabolism. Xanthine oxidase can exist in two interconvertible forms, either as xanthine dehydrogenase or xanthine oxidase. The aim of the paper was investigate the activity xanthine oxidoreductase in the plasma patients with age related cataract, with hypertensive, and with heart failure. Clinical and biochemical researches were carried out in 73 patients with age related cataract, mean age 72±7 years, divided into group with hypertensive (N=35), with heart failure (N=22) and group normotensive and without heart failure (N=16). Plasma xanthine oxidoreductase activity was determined spectrophotometrically by measuring the formation of uric acid from hypoxanthine at 293 nm. The concentration of triglycerides (TG), total cholesterol (TC), LDL-C, HDL-C in plasma were determined. Our findings show a significantly increased activity xanthine oxidoreductase in plasma hypertensive patients (XO 9.18±1.5 U/L) (p< 0.001) and patients with heart failure (XO 10.44±1.53U/L) (p< 0.001), compared with values plasma xanthine oxidoreductase activity in normotensive and patients without heart failure (XOD 6.02±1.4 U/L). Concentrations of plasma TG, TC and LDL-C were elevated in groups with hypertensive and with heart failure, and we to find significant differences with group normotensive and without heart failure values. Elevated activity of plasma xanthine oxidoreductase contribute to the increasåd oxidative stress and may play a role in accelerated atherosclerosis. 

Keywords

References

1.
Battelli MG, Abbondanza A, Musiani S, Buonamici L, Strocchi P, Tazzari PL, et al. Determination of xanthine oxidase in human serum by a competitive enzyme-linked immunosorbent assay (ELISA. Clin Chim Acta. 281:147–58.
2.
Bergmayer UH. Methoden Der Enzymatischen Analyse.
3.
Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res. 87(10):840–4.
4.
Chaves FJ, Corella D, Blesa S, Mansego ML, Marín P, Portoles O, et al. Xanthine oxidoreductase polymorphisms: Influence on blood pressure and oxidative stress levels. Pharmacogenet Genomics. 17(8):589–96.
5.
Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension. 31:162–9.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by